NLFBS.PA $0.00 0%
MANU $18.03 -1.8508%
OVB $20.88 -0.5932%
8055.HK $0.01 0%
0UKI.L $66.33 0.6718%
SAN $3.37 -1.0294%
KOCG $21.34 0.1996%
RGS $1.00 -1.9608%
XLK $149.91 -0.8204%
HQY $54.86 -0.0364%
PHM $67.84 -0.411%
GDYNW $14.23 0%
KTEC $11.76 -2.8099%
HNST $2.02 -4.5024%
0925.HK $0.07 2.7778%
OILD $30.99 1.0434%
VULC3.SA $14.47 -2.2297%
0RU6.L $121.99 -1.7755%
GRCY $11.24 -0.7067%
CXAU.L $188.45 0.2367%
MELE.BR $83.70 0.8434%
BALM3.SA $10.30 0%
SEE $41.86 -0.7822%
BIP $35.62 1.2507%
RTC.L $17.00 0%
DFJ $67.75 -0.2588%
CTEK $1.25 0%
NOVN $1.27 -0.7812%
SANM $50.08 -6.4799%
0938.HK $1.78 -4.3011%
ACKIW $0.00 0%
RCLFW $0.15 0%
AURC $10.17 -0.1953%
RS2U.L $253.05 -1.1137%
8502.HK $0.33 -5.7971%
FPEI $16.52 0%
CBA.L $38.00 0%
EINC $60.39 0.2853%
SIDU $0.24 0.6996%
ONEM $16.47 0%
ESGG.L $4 644.50 0.5847%
3315.HK $1.72 0.5848%
1093.HK $7.68 -0.3891%
2805.HK $30.88 0%
ASEA $15.05 -1.2461%
PLX $2.28 -10.549%
ER0.SI $0.34 0%
1397.HK $0.58 0%
0526.HK $0.04 -2.3256%
HMTV $7.15 0%
MLAEM.PA $3.46 0%
IGAS.L $16.25 -5.7971%
OMEG $10.10 0%
ALTG-PA $25.40 -0.3918%
AMRN $1.22 3.3898%
USB-PQ $15.51 -0.4814%
QFIN $17.18 -2.1083%
0HKM.L $4.10 -4.8886%
VPCBW $0.00 0%
HDGE $27.19 1.5742%
SCHL $39.65 0.456%
FMHI $47.03 0.0425%
1837.HK $0.49 0%
GWX $31.04 -0.6564%
DUETW $0.03 44%
IYE $41.17 -0.0486%
VBR $151.49 -0.6395%
BPOPN $25.23 0%
CHF.L $1.04 -0.5714%
APLS $88.21 -0.3727%
FLBR $18.29 0.4279%
SPPC.L $2.40 0%
0R3E.L $448.41 -0.3157%
VTEX $3.89 0%
SFIX $2.88 -9.9219%
AGYS $76.42 -0.8499%
EGRA.L $23.24 0.0861%
MLERO.PA $2.74 -2.1429%
FAST $54.28 -1.0753%
PNBK $7.05 -7.3587%
1570.HK $4.18 4.5%
CFACU $8.89 0%
NSPR $1.49 8.7591%
FBC $37.54 0%
GMIIW $1.19 0%
1620.HK $0.12 -3.876%
NEWT $10.81 -3.0493%
DTEA $0.52 0%
UAUD $15.09 0%
MTU.L $107.50 1.1765%
PAXG.L $7 658.00 -0.28%
MLHPE.PA $5.00 0%
JUGG $10.29 0%
SPGI $357.10 -0.8868%
CHPMW $0.00 0%
SXLV.L $39.30 0.1115%
GBX $26.14 -2.2438%
RICE-UN $21.54 0%
PILL $8.62 -4.1168%
JMBP.L $61.84 0%
Eng
Логотип
Eng
Лого

ASIT Biotech S.A. ASIT.BR

$0.23

На 18:01, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    0.00000000

  • week52high

    0.65

  • week52low

    0.19

  • Revenue

    0

  • P/E TTM

    -3

  • Beta

    1.33101200

  • EPS

    -0.00700000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    30 сент 2020 г. в 04:00

Описание компании

ASIT Biotech S.A., a biopharmaceutical company, focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies in Belgium and internationally. Its lead product is gp-ASIT+, which is in the Phase III trial for the treatment of grass pollen rhinitis. The company is also developing hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy. ASIT Biotech S.A. was incorporated in 1997 and is based in Liege, Belgium.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек